| 标题 |
 Rezivertinib versus gefitinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer (REZOR): a multicentre, double-blind, randomised, phase 3 study |
| 网址 | |
| DOI | |
| 其它 |
期刊：The Lancet Respiratory Medicine 作者：Yuankai Shi; Yanzhen Guo; Xingya Li; Lin Wu; Zhaohong Chen; et al 出版日期：2025-02-03 |
| 求助人 | |
| 下载 | 求助已完成，仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)
Kao
大力的冬萱
v0id
cdercder
yjh123
ale
张欢馨
OK
prigogin
十三
aaaa
Avalonx
arniu2008
行走的荷尔蒙
热心的粉红小企鹅
丰富语蕊
Nole
GingerF
Oracle
lx
皖公网安备34019202002308
